Tuesday, May 4, 2010

FDA Wants Infusion Pump Risk Reduction

The U.S. Food and Drug Administration (FDA) announced a new initiative to address safety problems associated with external infusion pumps, which are devices that deliver fluids, including nutrients and medications, into a patient’s body in a controlled manner.

As part of its initiative, FDA is moving to establish additional premarket requirements for infusion pumps, in part through issuance today of a new draft guidance and letter to infusion pump manufacturers. FDA is also announcing a May public workshop on infusion pump design, and launching a new Web page devoted to infusion pump safety, FDA - Infusion Pumps.

Although this is directed toward manufacturers, it's probably a good idea for everybody using pumps to follow what emerges from this initiative.

California HMDR Exemptee License Training Certification Course

Return Home:  The Designated Representative and Exemptee Blog

For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

1 comment:

Note: Only a member of this blog may post a comment.

Custom Search

From SkillsPlus International Inc.